Lockdowns vindicated by the vaccine, say the crazies
minds.com
Get replies from creators like MacKenzie
Truth about Gilead
https://www.google.com/amp/s/www.fool.com/amp/investing/2020/11/04/will-gileads-remdesivir-only-be-a-short-lived-succ/
Gilead Sciences Inc.’s prominent COVID-19 drug unexpectedly brought in $100 more million in sales than analysts had expected in the third quarter, but that...
google.com
https://www.google.com/amp/s/www.marketwatch.com/amp/story/gilead-unexpectedly-cashes-in-with-nearly-900-million-in-sales-of-covid-19-drug-2020-10-29
In the four months since Gilead Sciences Inc. first received emergency authorization for its experimental COVID-19 drug remdesivir, its stock has done the...
marketwatch.com
https://www.marketwatch.com/amp/story/gileads-stock-has-fallen-21-since-april-30-underscoring-investor-questions-about-remdesivirs-potential-2020-08-31